Tissue Regenix Group (LSE:TRX) Total Assets : £34.16 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group Total Assets?

Tissue Regenix Group's Total Assets for the quarter that ended in Dec. 2023 was £34.16 Mil.

During the past 12 months, Tissue Regenix Group's average Total Assets Growth Rate was -7.40% per year. During the past 3 years, the average Total Assets Growth Rate was 3.10% per year. During the past 5 years, the average Total Assets Growth Rate was 1.80% per year. During the past 10 years, the average Total Assets Growth Rate was 45.50% per year.

During the past 13 years, Tissue Regenix Group's highest 3-Year average Total Assets Growth Rate was 339.50%. The lowest was -35.50%. And the median was 51.60%.

Total Assets is connected with ROA %. Tissue Regenix Group's annualized ROA % for the quarter that ended in Dec. 2023 was -3.72%. Total Assets is also linked to Revenue through Asset Turnover. Tissue Regenix Group's Asset Turnover for the quarter that ended in Dec. 2023 was 0.35.

Tissue Regenix Group Total Assets Historical Data

The historical data trend for Tissue Regenix Group's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group Total Assets Chart

Tissue Regenix Group Annual Data

Trend

Jan14

Jan15

Jan16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

30.51

37.45

34.76

37.80

34.16

Tissue Regenix Group Semi-Annual Data
	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															34.76	36.12	37.80	35.59	34.16

Tissue Regenix Group Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Tissue Regenix Group's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	23.19	+	10.972
	=	34.16

Tissue Regenix Group's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	23.19	+	10.972
	=	34.16

Tissue Regenix Group (LSE:TRX) Total Assets Explanation

Total Assets is connected with ROA %.

Tissue Regenix Group's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-1.296	/	( (35.591	+	34.162)	/ 2 )
	=	-1.296	/	34.8765
	=	-3.72 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Tissue Regenix Group's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	12.162	/	( (35.591	+	34.162)	/ 2 )
=	12.162	/	34.8765
=	0.35

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Tissue Regenix Group Total Assets Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tissue Regenix Group (LSE:TRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

LSW:Germany

Address

Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY

Website

https://www.tissueregenix.com

Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.